EQ Stock Summary and Trading Ideas (Equillium | NASDAQ:EQ)

Equillium Inc is a biotechnology developing therapies to treat severe autoimmune and inflammatory disorders. Its pipeline includes itolizumab, a first-in-class antibody targeting the CD6-ALCAM pathway which plays a key role in the modulation of effector T cells - currently in a Ph 3 study for patients with acute graft-versus-host disease and a Ph 1b study for patients with lupus nephritis. EQ101, a first-in-class cytokine inhibitor that selectively targets IL-2, IL-9, and IL-15 is Ph2-ready and expected to begin enrolling patients in an alopecia areata study in 2H 2022. EQ102, a cytokine inhibitor that selectively targets IL-15 and IL-21, is ready for clinical development and expected to begin enrolling patients in a Ph 1study including patients with celiac disease.

Equillium trades on the NASDAQ stock market under the symbol EQ.

As of April 19, 2024, EQ stock price declined to $1.61 with 102,976 million shares trading.

EQ has a beta of 0.48, meaning it tends to be less sensitive to market movements. EQ has a correlation of 0.00 to the broad based SPY ETF.

EQ has a market cap of $56.76 million. This is considered a Micro Cap stock.

Last quarter Equillium reported $9 million in Revenue and -$.07 earnings per share. This beat revenue expectation by $361,000 and exceeded earnings estimates by $.10.

In the last 3 years, EQ stock traded as high as $7.75 and as low as $.45.

The top ETF exchange traded funds that EQ belongs to (by Net Assets): VTI, VXF, AVUV.

EQ has outperformed the market in the last year with a return of +130.0%, while the SPY ETF gained +21.2%. In the last 3 month period, EQ beat the market returning +103.8%, while SPY returned +4.3%. However, in the most recent 2 weeks EQ has underperformed the stock market by returning -27.5%, while SPY returned -3.5%.

EQ support price is $1.61 and resistance is $1.85 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that EQ stock will trade within this expected range on the day.